construction of influenza a/h1n1 virosomal nanobioparticles

Construction of Influenza A/H1N1 Virosomal Nanobioparticles

Background and Aims: Influenza is one of the main respiratory infections of humans, responsible for 300,000–500,000 annual deaths world-wide. Vaccination is one of the best ways to prevent infections including influenza. Influenza virosomes are virus-like particles, which retain the cell binding and membrane fusion properties of the native virus, but lack the ribonucleoprotein (RNP). A vi...

Predicting AH1N1 2009 influenza epidemic in Southeast Europe

AIM To use the data on the AH1N1 2009 influenza epidemic in the Southern hemisphere countries to predict the course and size of the upcoming influenza epidemic in South-Eastern Europe (SEE) countries and other regions of the World with temperate climate. METHOD We used a comparative epidemiological method to evaluate accessible electronic data on laboratory-confirmed deaths from AH1N1 2009 in...

ECMO, ARDS and AH1N1

Variability of influenza AH1N1 infections in a neonatal unit in Spain.

We describe three positive influenza AH1N1 cases in a neonatal unit during the influenza pandemic in Spain. One term baby presented with an upper respiratory tract infection, another preterm infant with an apnea episode following nosocomial infection, and thirdly, a term infant of a mother with influenza AH1N1 had severe respiratory distress and pneumothoraces needing high-frequency ventilation.

Incidental late diagnosis of cystic fibrosis following AH1N1 influenza virus pneumonia: a case report

BACKGROUND Cystic fibrosis is an autosomal recessive disorder characterized by chronic progressive multisystem involvement. AH1N1 virus infections caused classic influenza symptoms in the majority of cystic fibrosis patients while others experienced severe outcomes. CASE PRESENTATION We report a case of late incidental cystic fibrosis diagnosis in a young Caucasian man suffering from respirat...

Utility of virosomal adjuvated influenza vaccines: a review of the literature.

In spite of the efforts of the World Health Organization (WHO), influenza continues to be a major public health problem, both because of its impact on the health of subjects at risk, such as the elderly, and because of the economic burden that it places on society. Adjuvants are agents which, when incorporated into vaccines, enhance the immunogenicity of their antigens. The need for ever more i...